Immunology of Cutaneous Vasculitis Associated with both Etanercept and Infliximab
- 22 April 2005
- journal article
- case report
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 61 (4), 329-336
- https://doi.org/10.1111/j.1365-3083.2005.01570.x
Abstract
Targeted inhibition of tumour necrosis factor-alpha (TNF-alpha) is an effective therapy in rheumatoid arthritis and Crohn's disease (CD). Infliximab, a monoclonal murine-human chimeric antibody to TNF-alpha, and etanercept, a fusion protein of two p75 chains of the TNF receptor II and the Fc portion of IgG1, are generally well tolerated. Rarely does clinically significant autoimmunity, including drug-induced lupus and vasculitis occur. Immunologic mechanisms underlying the development of autoimmunity in the presence of such powerful immunosuppressants are unknown. We describe a patient with CD, who developed cutaneous vasculitis on etanercept, which worsened significantly with switch to infliximab. Investigation of the associated systemic and local immune response demonstrated the absence of human antichimera antibodies, but mRNA for T-helper 1 cytokines, chemokines and defensins in the skin and elevated angiogenesis factors in the serum, as determined by reverse-transcriptase polymerase chain reaction and enzyme-linked immunosorbent assay. Histopathology revealed a lymphocytic vasculitis composed of T cells. A permanent B-cell line (MD-B) producing extremely high amounts of chemokines and interleukin-6 was established from this patient's peripheral blood. Lesions progressed despite discontinuation of the drugs and (40 mg/day) prednisone but almost completely resolved with single dose of (0.1 mg/kg) intravenous dexamethasone, which may be therapy of choice for this reaction. A few lesions (<10) have recurred intermittently over 4 years of follow-up, suggesting possible persistence of this TNF-inhibitor-triggered autoimmune disease.Keywords
This publication has 20 references indexed in Scilit:
- A Pilot Study of Adalimumab in Infliximab-Allergic PatientsInflammatory Bowel Diseases, 2004
- Autoimmunity associated with anti-tumor necrosis factor α treatment in Crohn’s disease: a prospective cohort studyGastroenterology, 2003
- Vasculitis in childhoodRheumatic Disease Clinics of North America, 2002
- Adverse reactions to TNF-α inhibitors in rheumatoid arthritisThe Lancet, 2002
- InfliximabBioDrugs, 2002
- Human beta-defensin-2The International Journal of Biochemistry & Cell Biology, 1999
- Immunology of endometriosisJournal of Reproductive Immunology, 1999
- Regulation of Human IL-18 mRNA ExpressionClinical Immunology, 1999
- Characterization of mRNA Expression of IκBα and NF-κB Subfamilies in Primary Adult T-cell Leukemia CellsJapanese Journal of Cancer Research, 1998
- REGULATION OF FAS AND FAS-LIGAND EXPRESSION IN NK CELLS BY CYTOKINES AND THE INVOLVEMENT OF FAS-LIGAND IN NK/LAK CELL-MEDIATED CYTOTOXICITYCytokine, 1997